The purpose of this research is to examine the effects of long-term aerobic exercise of moderate intensity on psychological, physiological, biochemical, physiological and alcohol-related parameters in heavy drinkers, in order to investigate possible biochemical mechanisms by which exercise may be a healthy alternative to alcohol abuse.
The mechanism of incentives that lead people to unhealthy habits such as excessive alcohol consumption is not only social, personal, and psychological, but also associated with neurochemical and neurobiological mechanisms. Several programs have been developed to stop excessive drinking, but the success rates are small, while the relapse rates are very high, reaching up to 90%. Although there is some evidence for the beneficial effects of exercise on alcohol use disorders, research is limited. The present study investigates whether exercise can act as adjunct therapy for alcohol abuse cessation. One of the basic assumptions is that the appropriate form of exercise in alcoholics will contribute to the secretion of beta-endorphin, which in combination with psychological pleasure, vitality, change of mood, reduced stress, increased confidence, and the shift of attention will help people to follow healthy lifestyles and abhor alcohol. The research project is divided in three phases. In the first phase, the effect of acute exercise in critical psychological, physiological, biochemical and alcohol-related parameters associated with excessive alcohol consumption will be examined. In the second phase (current study), a long-term exercise program in conjunction with psychological support strategies aimed at alcohol abuse cessation will be developed, implemented and evaluated. Finally, in the third phase, based on the results of the previous phases, awareness programs in adolescent and adult populations will be designed and implemented as well as the dissemination of results and evaluation of the project will take place.
Study Type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
13
Supervised 8-week exercise training program. Aerobic exercise (walking, jogging) of increasing duration at 50-60% HRR, at least two sessions per week. Participants will be recording their daily alcohol consumption. Participants will also undergo three trials of acute exercise (before, at the 4th week and at the 8th week of exercise training) in order to investigate whether exercise training can lead to changes in acute responses to exercise. Each trial involves 30 min of exercise on a cycle ergometer at 50-60% HRR.
Changes in alcohol consumption (grams of alcohol consumed weekly)
Self-recorded
Time frame: At baseline and at 4th week of control condition; at baseline (before intervention), at 4th week and at 8th week of intervention
Changes in Beta-endorphin levels
Measured by radioimmunoassay (RIA)
Time frame: At baseline and at 4th week of control condition; at baseline (before intervention), at 4th week and at 8th week of intervention
Urge to drink
According to questionnaire
Time frame: At baseline and at 4th week of control condition; at baseline (before intervention), at 4th week and at 8th week of intervention
Cortisol
Measured by radioimmunoassay (RIA)
Time frame: At baseline and at 4th week of control condition; at baseline (before intervention), at 4th week and at 8th week of intervention
Adrenocorticotrophic hormone (ACTH)
Measured by radioimmunoassay (RIA)
Time frame: At baseline and at 4th week of control condition; at baseline (before intervention), at 4th week and at 8th week of intervention
Catecholamines (epinephrine, norepinephrine, dopamine)
Measured by radioimmunoassay (RIA)
Time frame: At baseline and at 4th week of control condition; at baseline (before intervention), at 4th week and at 8th week of intervention
C-reactive protein (CRP)
Semi-quantitative estimation with CRP Latex test kit
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Time frame: At baseline and at 4th week of control condition; at baseline (before intervention), at 4th week and at 8th week of intervention
Complete blood count
Autoanalyzer Autoanalyzer Autoanalyzer
Time frame: At baseline and at 4th week of control condition; at baseline (before intervention), at 4th week and at 8th week of intervention
Lactic acid
Measured using photometry
Time frame: At baseline and at 4th week of control condition; at baseline (before intervention), at 4th week and at 8th week of intervention
Erythrocyte sedimentation rate (ESR)
Wintrobe Method
Time frame: At baseline and at 4th week of control condition; at baseline (before intervention), at 4th week and at 8th week of intervention
γ-Glutamyltransferase (GGT)
Measured with commercial kit
Time frame: At baseline and at 4th week of control condition; at baseline (before intervention), at 4th week and at 8th week of intervention
Aspartate Aminotransferase (AST)
Measured with commercial kit
Time frame: At baseline and at 4th week of control condition; at baseline (before intervention), at 4th week and at 8th week of intervention
Alanine Aminotransferase (ALT)
Measured with commercial kit
Time frame: At baseline and at 4th week of control condition; at baseline (before intervention), at 4th week and at 8th week of intervention
Sit and reach flexibility test for the hamstrings muscles and lower back
Each participant sits on the floor with legs stretched out straight ahead, reaches out and holds that position for at 1-2 seconds while the distance is recorded.
Time frame: At baseline and at 4th week of control condition; at baseline (before intervention), at 4th week and at 8th week of intervention
Grip strength
Handgrip strength test
Time frame: At baseline and at 4th week of control condition; at baseline (before intervention), at 4th week and at 8th week of intervention
Number of push-ups performed in one minute
Time frame: At baseline and at 4th week of control condition; at baseline (before intervention), at 4th week and at 8th week of intervention
Number of sit-ups performed until exhaustion
Time frame: At baseline and at 4th week of control condition; at baseline (before intervention), at 4th week and at 8th week of intervention